Unraveling the Potential Drug Target and Biomarker C10orf105: A Protein associated with Multiple Chronic Diseases

Target Name: C10orf105

NCBI ID: G414152

C10orf105

Other Name(s): Uncharacterized protein C10orf105 | chromosome 10 open reading frame 105 | CJ105_HUMAN | Chromosome 10 open reading frame 105, transcript variant 1

Unraveling the Potential Drug Target and Biomarker C10orf105: A Protein associated with Multiple Chronic Diseases

Introduction

C10orf105 is a protein located in chromosome 10p62.2 has been identified as a potential drug target and biomarker for various chronic diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its name derived from its position on the 10th chromosome, which is known as the C10 region, and the 105th gene, reflecting its location within the chromome.

C10orf105 is a 21-kDa protein that is expressed in various tissues and cells, including blood cells, tissues, and organs. It is involved in various cellular processes, including cell adhesion, migration, and survival signaling. Its function in these processes makes it a potential drug target for diseases that involve disruptions in cell signaling pathways.

Potential Drug Targets

C10orf105 has been implicated in the development and progression of various chronic diseases due to its involvement in signaling pathways that are often disrupted in these diseases. Some of the potential drug targets associated with C10orf105 include:

1. Cancer: C10orf105 has been shown to be involved in the development and progression of various types of cancer, including breast, ovarian, and prostate cancers. Its role in these processes makes it a potential target for cancer therapies that target signaling pathways involved in these diseases.
2. Neurodegenerative Diseases: C10orf105 has been linked to the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its involvement in signaling pathways that are often disrupted in these diseases makes it a potential target for therapies that target these pathways.
3. Autoimmune Disorders: C10orf105 has been implicated in the development and progression of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. Its role in these processes makes it a potential target for therapies that target signaling pathways involved in these disorders.

Biomarker Potential

C10orf105 has also been identified as a potential biomarker for various chronic diseases. Its presence and expression level in various tissues and fluids, such as blood, saliva, and urine, make it an attractive candidate for diagnostic applications. Additionally, its potential as a drug target makes it a potential indicator for disease progression and response to therapies.

Expression and regulation

Several studies have investigated the expression and regulation of C10orf105.expression and regulation. These studies have shown that C10orf105 is expressed in various tissues and cells and is regulated by various signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT signaling pathways.

One of the most significant findings in the regulation of C10orf105 is its interaction with the transcription factor, NF-kappa-B. Studies have shown that C10orf105 can physically interact with the NF-kappa-B receptor, leading to increased NF-kappa-B activity and gene expression. This The interaction between C10orf105 and NF-kappa-B suggests a potential role for this protein in the regulation of cellular processes that are involved in the development and progression of chronic diseases.

The role of C10orf105 in signaling pathways is also regulated by the PI3K/AKT signaling pathway. This pathway is involved in the regulation of cell survival and metabolism and is a potential target for therapies that target signaling pathways involved in chronic diseases.

Discovery and development of C10orf105 as a drug target

The discovery of C10orf105 as a potential drug target and biomarker has been a challenging process, but recent studies have shown significant progress in this field.

Initial screening for potential drug targets based on C10orf105 expression and function led to the identification of several potential targets, including the PI3K/AKT pathway. Further studies have shown that inhibition of the PI3K/AKT pathway can lead to significant improvements in the expression and function of C10orf105, suggesting a potential role for this protein in the regulation of cellular processes that are involved in the development and progression of chronic diseases.

Conclusion

C10orf105 is a protein that has been identified as a potential drug target and biomarker for various chronic diseases due to its involvement in signaling pathways that are often disrupted in these diseases. Its function in these processes makes it a potential target for therapies that target these pathways . Additionally, its potential as a biomarker makes it an attractive candidate for diagnostic applications. Further studies are needed to fully understand the role of C10orf105 in the development and progression of chronic diseases and to identify effective therapies that target this protein.

Protein Name: Chromosome 10 Open Reading Frame 105

The "C10orf105 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C10orf105 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets